Bioactivity-Driven Synthesis of the Marine Natural Product Naamidine J and Its Derivatives as Potential Tumor Immunological Agents by Inhibiting Programmed Death-Ligand 1-Reference-Cited by-同舟云学术

Bioactivity-Driven Synthesis of the Marine Natural Product Naamidine J and Its Derivatives as Potential Tumor Immunological Agents by Inhibiting Programmed Death-Ligand 1

Published:2023-04-11 Issue:8 Volume:66 Page:5427-5438
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Fu Pan-Pan¹²,Wang Qun³,Zhang Qing³,Jin Yang¹,Liu Jin¹,Chen Kai-Xian¹,Guo Yue-Wei¹²^ORCID,Liu San-Hong³^ORCID,Li Xu-Wen¹²^ORCID

Affiliation:

1. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2. Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China

3. Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Shanghai Rising-Star Program

Chinese Academy of Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01702

Reference36 articles.

1. Delivery technologies for cancer immunotherapy

2. Cancer immunoediting and resistance to T cell-based immunotherapy

3. LAG-3: from molecular functions to clinical applications

4. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

5. CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape